<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02551198</url>
  </required_header>
  <id_info>
    <org_study_id>NCC2015-0210</org_study_id>
    <nct_id>NCT02551198</nct_id>
  </id_info>
  <brief_title>Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation</brief_title>
  <official_title>Comparative Evaluation the Efficacy of 2L Polyethylene Glycol With Ascorbic Acid (PEG-Asc) and Oral Sulfate Solution (OSS) in Split Method for Bowel Preparation (The Phase III Prospective Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Daehang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colonoscopy is considered by many the preferred mode of screening for colorectal cancer
      (CRC). The effectiveness of any CRC screening program is critically dependent on an adequate
      bowel preparation.

      For bowel preparation, effective, well-tolerated and safe methods should be applied.

      Recently, oral sulfate solution was adopted to Korea. Still, in Korea, there was no data of
      direct comparison of 2L polyethylene glycol with ascorbic acid (PEG-Asc) and oral sulfate
      solution (OSS) in split method for bowel preparation. Therefore, in this study, we planned
      the comparative evaluation the efficacy of PEG-Asc and OSS in split method for bowel
      preparation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For direct comparison of 2L polyethylene glycol with ascorbic acid (PEG-Asc) and oral sulfate
      solution (OSS) in split method for bowel preparation
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adequacy of bowel preparation</measure>
    <time_frame>on the day of colonoscopy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>5-point scale symptom questionnaire for drug tolerability</measure>
    <time_frame>on the day of colonoscopy</time_frame>
    <description>4(distressing) or 5(severely distressing) point would be untolerable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events</measure>
    <time_frame>on the day of colonoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>colonoscopy insertion time</measure>
    <time_frame>on the day of colonoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adenoma detection rate</measure>
    <time_frame>whithin 3 weeks from the day of colonoscopy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>HAPREP® (PEG-Asc)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects randomized to 2L polyethylene glycol with ascorbic acid (PEG-Asc) were instructed to use PEG-Asc for bowel preparation
: PEG-Asc(500mLx2 times q30min)[PM 7-9, the day before colonoscopy] + PEG-Asc(500mLx2 times q30min)[AM 5-7, the day of colonoscopy]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SUCLEAR® (OSS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects randomized to oral sulfate solution were instructed to use oral sulfate solution (OSS) for bowel preparation
: OSS(1b/177mL)[PM 7-9, the day before colonoscopy] + OSS(1b/177mL)[AM 5-7, the day of colonoscopy]</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HAPREP®</intervention_name>
    <description>Arm1: HAPREP® (2L polyethylene glycol with ascorbic acid; PEG-Asc)
: : PEG-Asc(500mLx2 times q30min)[PM 7-9, the day before colonoscopy] + PEG-Asc(500mLx2 times q30min)[AM 5-7, the day of colonoscopy]</description>
    <arm_group_label>HAPREP® (PEG-Asc)</arm_group_label>
    <other_name>2L polyethylene glycol with ascorbic acidl PEG-Asc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SUCLEAR®</intervention_name>
    <description>Arm2: SUCLEAR® (oral sulfate solution; OSS): OSS(1b/177mL)[PM 7-9, the day before colonoscopy] + OSS(1b/177mL)[AM 5-7, the day of colonoscopy]</description>
    <arm_group_label>SUCLEAR® (OSS)</arm_group_label>
    <other_name>oral sulfate solution; OSS,</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age, between 20 and 75

          2. Patients who were visited the outpatient clinic for National Cancer Cancer or Daehang
             hospital to undergo colonoscopy

        Exclusion Criteria:

          -  Gastrointestinal obstruction

          -  Bowel perforation

          -  Gastric retention

          -  Ileus

          -  Toxic colitis or toxic megacolon

          -  Known allergies to components of the OSS and PEG-Asc

          -  History of colorectal resection

          -  History of abdominopelvic surgery within 6 months

          -  uncontrolled electrolyte imbalance

          -  hereditary Phenylketonuria

          -  Severe dehydration status

          -  seizure

          -  coma

          -  Glucose-6-phosphate dehydrogenase deficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dae Kyung Sohn, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dae Kyung Sohn, M.D.</last_name>
    <phone>+82-31-920-1636</phone>
    <email>gsgsbal@ncc.re.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>410-769</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dae Kyung Sohn, MD,PHD</last_name>
      <phone>+82‐31‐920‐1636</phone>
      <email>gsgsbal@ncc.re.kr</email>
    </contact>
    <contact_backup>
      <last_name>Tae Young Chang</last_name>
      <phone>+82‐31‐920‐1761</phone>
      <email>12010@ncc.re.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Dae Kyung Sohn</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2015</study_first_submitted>
  <study_first_submitted_qc>September 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>November 25, 2015</last_update_submitted>
  <last_update_submitted_qc>November 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Dae Kyung Sohn</investigator_full_name>
    <investigator_title>M.D., PhD</investigator_title>
  </responsible_party>
  <keyword>polyethylene glycol with ascorbic acid</keyword>
  <keyword>oral sulfate solution</keyword>
  <keyword>bowel preparation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

